Medicinal Products

Abakavir/Lamivudin Mylan 600 mg/300 mg filmom obložene tablete

Name Abakavir/Lamivudin Mylan 600 mg/300 mg filmom obložene tablete
Marketing Authorisation Number HR-H-721934245
Active Substance abakavirklorid
lamivudin
Composition jedna filmom obložena tableta sadrži 600 mg abakavira (u obliku abakavirklorida) i 300 mg lamivudina
Pharmaceutical Form filmom obložena tableta
Packaging [MA Number for Packaging] 30 tableta u blisteru, u kutiji  [HR-H-721934245-01]
60 tableta u blisteru, u kutiji  [HR-H-721934245-02]
90 tableta u blisteru, u kutiji  [HR-H-721934245-03]
30 tableta u bočici, u kutiji  [HR-H-721934245-04]
Manufacturer Mylan S.A.S., Saint Priest, Francuska
McDermott Laboratories Limited t/a Gerard Laboratories t/a Mylan Dublin, Dublin, Irska
Mylan Hungary Kft, Komárom, Mađarska
Marketing Authorisation Holder Mylan Pharmaceuticals Limited, Damastown Industrial Park, Mulhuddart, Dublin, Irska
Marketing Authorisation Date 07.10.2021
MA Period of Validity 11.06.2023
Classification Number UP/I-530-09/16-01/307
Registration Number 381-12-01/70-21-31
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code J05AR02
Medicinal product marketed in the Croatia Da
SmPC download
PL download
Public Assessment Report download
Educational materials
for healthcare professionals
Prezentacija za zdravstvene radnike, verzija 3
Back